{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:13:06Z","timestamp":1787659986829,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00259-019-04357-w","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T05:02:38Z","timestamp":1559883758000},"page":"1952-1965","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Synthesis and in vivo evaluation of [18F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A)"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-8756","authenticated-orcid":false,"given":"Songye","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengxin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Holden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-fei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd J.","family":"Finnema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Shirali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Ropchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Carre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,7]]},"reference":[{"key":"4357_CR1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s40263-016-0384-x","volume":"30","author":"W Loscher","year":"2016","unstructured":"Loscher W, Gillard M, Sands ZA, Kaminski RM, Klitgaard H. Synaptic vesicle glycoprotein 2A ligands in the treatment of epilepsy and beyond. CNS Drugs. 2016;30:1055\u201377. \n                    https:\/\/doi.org\/10.1007\/s40263-016-0384-x\n                    \n                  .","journal-title":"CNS Drugs"},{"key":"4357_CR2","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1126\/science.1519064","volume":"257","author":"SM Bajjalieh","year":"1992","unstructured":"Bajjalieh SM, Peterson K, Shinghal R, Scheller RH. SV2, a brain synaptic vesicle protein homologous to bacterial transporters. Science. 1992;257:1271\u20133. \n                    https:\/\/doi.org\/10.1126\/science.1519064\n                    \n                  .","journal-title":"Science."},{"key":"4357_CR3","doi-asserted-by":"publisher","first-page":"15268","DOI":"10.1073\/pnas.96.26.15268","volume":"96","author":"KM Crowder","year":"1999","unstructured":"Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang HZ, Peterson MR, et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci U S A. 1999;96:15268\u201373. \n                    https:\/\/doi.org\/10.1073\/pnas.96.26.15268\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4357_CR4","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1111\/ejn.12360","volume":"38","author":"JG Mendoza-Torreblanca","year":"2013","unstructured":"Mendoza-Torreblanca JG, Vanoye-Carlo A, Phillips-Farfan BV, Carmona-Aparicio L, Gomez-Lira G. Synaptic vesicle protein 2A: basic facts and role in synaptic function. Eur J Neurosci. 2013;38:3529\u201339. \n                    https:\/\/doi.org\/10.1111\/ejn.12360\n                    \n                  .","journal-title":"Eur J Neurosci"},{"key":"4357_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12031-009-9288-2","volume":"39","author":"G Feng","year":"2009","unstructured":"Feng G, Xiao F, Lu Y, Huang Z, Yuan J, Xiao Z, et al. Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy. J Mol Neurosci. 2009;39:354\u20139. \n                    https:\/\/doi.org\/10.1007\/s12031-009-9288-2\n                    \n                  .","journal-title":"J Mol Neurosci"},{"key":"4357_CR6","doi-asserted-by":"publisher","first-page":"27420","DOI":"10.1038\/srep27420","volume":"6","author":"K Tokudome","year":"2016","unstructured":"Tokudome K, Okumura T, Shimizu S, Mashimo T, Takizawa A, Serikawa T, et al. Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission. Sci Rep. 2016;6:27420. \n                    https:\/\/doi.org\/10.1038\/srep27420\n                    \n                  .","journal-title":"Sci Rep"},{"key":"4357_CR7","doi-asserted-by":"publisher","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","volume":"109","author":"PE Sanchez","year":"2012","unstructured":"Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model. Proc Natl Acad Sci U S A. 2012;109:E2895.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4357_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3233\/JAD-150687","volume":"50","author":"C Stockburger","year":"2016","unstructured":"Stockburger C, Miano D, Baeumlisberger M, Pallas T, Arrey TN, Karas M, et al. A mitochondrial role of SV2a protein in aging and Alzheimer\u2019s disease: studies with Levetiracetam. J Alzheimers Dis. 2016;50:201\u201315. \n                    https:\/\/doi.org\/10.3233\/JAD-150687\n                    \n                  .","journal-title":"J Alzheimers Dis"},{"key":"4357_CR9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jocn.2009.07.101","volume":"17","author":"Z Hou","year":"2010","unstructured":"Hou Z, Lei H, Hong S, Sun B, Fang K, Lin X, et al. Functional changes in the frontal cortex in Parkinson\u2019s disease using a rat model. J Clin Neurosci. 2010;17:628\u201333. \n                    https:\/\/doi.org\/10.1016\/j.jocn.2009.07.101\n                    \n                  .","journal-title":"J Clin Neurosci"},{"key":"4357_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.schres.2012.08.027","volume":"141","author":"M Mattheisen","year":"2012","unstructured":"Mattheisen M, Muhleisen TW, Strohmaier J, Treutlein J, Nenadic I, Alblas M, et al. Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia. Schizophr Res. 2012;141:262\u20135. \n                    https:\/\/doi.org\/10.1016\/j.schres.2012.08.027\n                    \n                  .","journal-title":"Schizophr Res"},{"key":"4357_CR11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ. Alzheimer\u2019s disease is a synaptic failure. Science. 2002;298:789\u201391. \n                    https:\/\/doi.org\/10.1126\/science.1074069\n                    \n                  .","journal-title":"Science."},{"key":"4357_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:280\u201392. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003\n                    \n                  .","journal-title":"Alzheimers Dement"},{"key":"4357_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.nucmedbio.2016.03.004","volume":"43","author":"S Estrada","year":"2016","unstructured":"Estrada S, Lubberink M, Thibblin A, Sprycha M, Buchanan T, Mestdagh N, et al. [11C]UCB-A, a novel PET tracer for synaptic vesicle protein 2A. Nucl Med Biol. 2016;43:325\u201332. \n                    https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.03.004\n                    \n                  .","journal-title":"Nucl Med Biol"},{"key":"4357_CR14","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.2967\/jnumed.113.136143","volume":"55","author":"GI Warnock","year":"2014","unstructured":"Warnock GI, Aerts J, Bahri MA, Bretin F, Lemaire C, Giacomelli F, et al. Evaluation of 18F-UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain. J Nucl Med. 2014;55:1336\u201341. \n                    https:\/\/doi.org\/10.2967\/jnumed.113.136143\n                    \n                  .","journal-title":"J Nucl Med"},{"key":"4357_CR15","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/acs.molpharmaceut.7b00235","volume":"14","author":"G Becker","year":"2017","unstructured":"Becker G, Warnier C, Serrano ME, Bahri MA, Mercier J, Lemaire C, et al. Pharmacokinetic characterization of [18F]UCB-H PET radiopharmaceutical in the rat brain. Mol Pharm. 2017;14:2719\u201325. \n                    https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00235\n                    \n                  .","journal-title":"Mol Pharm"},{"key":"4357_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s11307-014-0820-6","volume":"17","author":"F Bretin","year":"2015","unstructured":"Bretin F, Bahri MA, Bernard C, Warnock G, Aerts J, Mestdagh N, et al. Biodistribution and radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H: first-in-human study. Mol Imaging Biol. 2015;17:557\u201364. \n                    https:\/\/doi.org\/10.1007\/s11307-014-0820-6\n                    \n                  .","journal-title":"Mol Imaging Biol"},{"key":"4357_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.trci.2017.08.004","volume":"3","author":"MA Bahri","year":"2017","unstructured":"Bahri MA, Plenevaux A, Aerts J, Bastin C, Becker G, Mercier J, et al. Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F]UCB-H. Alzheimers Dement (NY). 2017;3:481\u20136. \n                    https:\/\/doi.org\/10.1016\/j.trci.2017.08.004\n                    \n                  .","journal-title":"Alzheimers Dement (NY)"},{"key":"4357_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/cmdc.201300482","volume":"9","author":"J Mercier","year":"2014","unstructured":"Mercier J, Archen L, Bollu V, Carre S, Evrard Y, Jnoff E, et al. Discovery of heterocyclic nonacetamide synaptic vesicle protein 2A (SV2A) ligands with single-digit nanomolar potency: opening avenues towards the first SV2A positron emission tomography (PET) ligands. ChemMedChem. 2014;9:693\u20138. \n                    https:\/\/doi.org\/10.1002\/cmdc.201300482\n                    \n                  .","journal-title":"ChemMedChem."},{"key":"4357_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2967\/jnumed.115.168179","volume":"57","author":"NB Nabulsi","year":"2016","unstructured":"Nabulsi NB, Mercier J, Holden D, Carre S, Najafzadeh S, Vandergeten MC, et al. Synthesis and preclinical evaluation of 11C-UCB-J as a PET tracer for imaging the synaptic vesicle glycoprotein 2A in the brain. J Nucl Med. 2016;57:777\u201384. \n                    https:\/\/doi.org\/10.2967\/jnumed.115.168179\n                    \n                  .","journal-title":"J Nucl Med"},{"key":"4357_CR20","doi-asserted-by":"publisher","unstructured":"Finnema SJ, Nabulsi NB, Mercier J, Lin SF, Chen MK, Matuskey D, et al. Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans. J Cereb Blood Flow Metab. 2017:271678X17724947. doi:\n                    https:\/\/doi.org\/10.1177\/0271678X17724947\n                    \n                  .","DOI":"10.1177\/0271678X17724947"},{"key":"4357_CR21","doi-asserted-by":"publisher","first-page":"348ra96","DOI":"10.1126\/scitranslmed.aaf6667","volume":"8","author":"SJ Finnema","year":"2016","unstructured":"Finnema SJ, Nabulsi NB, Eid T, Detyniecki K, Lin SF, Chen MK, et al. Imaging synaptic density in the living human brain. Sci Transl Med. 2016;8:348ra96. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aaf6667\n                    \n                  .","journal-title":"Sci Transl Med"},{"key":"4357_CR22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712\u20136. \n                    https:\/\/doi.org\/10.1126\/science.aad8373\n                    \n                  .","journal-title":"Science."},{"key":"4357_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11910-010-0104-8","volume":"10","author":"M van Spronsen","year":"2010","unstructured":"van Spronsen M, Hoogenraad CC. Synapse pathology in psychiatric and neurologic disease. Curr Neurol Neurosci Rep. 2010;10:207\u201314. \n                    https:\/\/doi.org\/10.1007\/s11910-010-0104-8\n                    \n                  .","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4357_CR24","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/ana.24394","volume":"77","author":"AC Kaufman","year":"2015","unstructured":"Kaufman AC, Salazar SV, Haas LT, Yang J, Kostylev MA, Jeng AT, et al. Fyn inhibition rescues established memory and synapse loss in Alzheimer mice. Ann Neurol. 2015;77:953\u201371. \n                    https:\/\/doi.org\/10.1002\/ana.24394\n                    \n                  .","journal-title":"Ann Neurol"},{"key":"4357_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.celrep.2017.06.023","volume":"20","author":"LT Haas","year":"2017","unstructured":"Haas LT, Salazar SV, Smith LM, Zhao HR, Cox TO, Herber CS, et al. Silent allosteric modulation of mGluR5 maintains glutamate signaling while rescuing Alzheimer\u2019s mouse phenotypes. Cell Rep. 2017;20:76\u201388. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2017.06.023\n                    \n                  .","journal-title":"Cell Rep"},{"key":"4357_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0969-8051(00)00125-6","volume":"27","author":"J Hilton","year":"2000","unstructured":"Hilton J, Yokoi F, Dannals RF, Ravert HT, Szabo Z, Wong DF. Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl Med Biol. 2000;27:627\u201330.","journal-title":"Nucl Med Biol"},{"key":"4357_CR27","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","volume":"75","author":"MK Chen","year":"2018","unstructured":"Chen MK, Mecca AP, Naganawa M, Finnema SJ, Toyonaga T, Lin SF, et al. Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging. JAMA Neurol. 2018;75:1215\u201324. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2018.1836\n                    \n                  .","journal-title":"JAMA Neurol"},{"key":"4357_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neuroimage.2012.08.051","volume":"64","author":"CM Sandiego","year":"2013","unstructured":"Sandiego CM, Weinzimmer D, Carson RE. Optimization of PET-MR registrations for nonhuman primates using mutual information measures: a multi-transform method (MTM). Neuroimage. 2013;64:571\u201381. \n                    https:\/\/doi.org\/10.1016\/j.neuroimage.2012.08.051\n                    \n                  .","journal-title":"Neuroimage."},{"key":"4357_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00004647-200106000-00002","volume":"21","author":"RN Gunn","year":"2001","unstructured":"Gunn RN, Gunn SR, Cunningham VJ. Positron emission tomography compartmental models. J Cereb Blood Flow Metab. 2001;21:635\u201352. \n                    https:\/\/doi.org\/10.1097\/00004647-200106000-00002\n                    \n                  .","journal-title":"J Cereb Blood Flow Metab"},{"key":"4357_CR30","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533\u20139. \n                    https:\/\/doi.org\/10.1038\/sj.jcbfm.9600493\n                    \n                  .","journal-title":"J Cereb Blood Flow Metab"},{"key":"4357_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/jcbfm.2009.190","volume":"30","author":"VJ Cunningham","year":"2010","unstructured":"Cunningham VJ, Rabiner EA, Slifstein M, Laruelle M, Gunn RN. Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited. J Cereb Blood Flow Metab. 2010;30:46\u201350. \n                    https:\/\/doi.org\/10.1038\/jcbfm.2009.190\n                    \n                  .","journal-title":"J Cereb Blood Flow Metab"},{"key":"4357_CR32","doi-asserted-by":"publisher","unstructured":"Pike VW, Aigbirhio FI. Reactions of cyclotron-produced [18F]fluoride with diaryliodonium salts-a novel single-step route to no-carrier-added [18]fluoroarenes. J Chem Soc Chem Commun. 1995:2215\u20136. \n                    https:\/\/doi.org\/10.1039\/C39950002215\n                    \n                  .","DOI":"10.1039\/C39950002215"},{"key":"4357_CR33","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1038\/ncomms5365","volume":"5","author":"BH Rotstein","year":"2014","unstructured":"Rotstein BH, Stephenson NA, Vasdev N, Liang SH. Spirocyclic hypervalent iodine(III)-mediated radiofluorination of non-activated and hindered aromatics. Nat Commun. 2014;5:4365. \n                    https:\/\/doi.org\/10.1038\/ncomms5365\n                    \n                  .","journal-title":"Nat Commun"},{"key":"4357_CR34","doi-asserted-by":"publisher","first-page":"17293","DOI":"10.1039\/C4RA00674G","volume":"4","author":"J Cardinale","year":"2014","unstructured":"Cardinale J, Ermert J, Humpert S, Coenen HH. Iodonium ylides for one-step, no-carrier-added radiofluorination of electron rich arenes, exemplified with 4-(([F-18] fluorophenoxy)-phenylmethyl) piperidine NET and SERT ligands. RSC Adv. 2014;4:17293\u20139. \n                    https:\/\/doi.org\/10.1039\/c4ra00674g\n                    \n                  .","journal-title":"RSC Adv"},{"key":"4357_CR35","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1039\/C7CY00538E","volume":"7","author":"XD Jin","year":"2017","unstructured":"Jin XD, Davies RP. Copper-catalysed aromatic-Finkelstein reactions with amine-based ligand systems. Catal Sci Technol. 2017;7:2110\u20137. \n                    https:\/\/doi.org\/10.1039\/c7cy00538e\n                    \n                  .","journal-title":"Catal Sci Technol"},{"key":"4357_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/open.201300042","volume":"3","author":"M Bielawski","year":"2014","unstructured":"Bielawski M, Malmgren J, Pardo LM, Wikmark Y, Olofsson B. One-pot synthesis and applications of N-heteroaryl iodonium salts. Chemistryopen. 2014;3:19\u201322. \n                    https:\/\/doi.org\/10.1002\/open.201300042\n                    \n                  .","journal-title":"Chemistryopen."},{"key":"4357_CR37","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature19311","volume":"538","author":"CN Neumann","year":"2016","unstructured":"Neumann CN, Hooker JM, Ritter T. Concerted nucleophilic aromatic substitution with 19F\u2212 and 18F. Nature. 2016;538:274. \n                    https:\/\/doi.org\/10.1038\/nature19311\n                    \n                  .","journal-title":"Nature."},{"key":"4357_CR38","doi-asserted-by":"publisher","unstructured":"Makaravage KJ, Brooks AF, Mossine AV, Sanford MS, Scott PJ. Copper-mediated Radiofluorination of Arylstannanes with [18F]KF. Org Lett. 2016. \n                    https:\/\/doi.org\/10.1021\/acs.orglett.6b02911\n                    \n                  .","DOI":"10.1021\/acs.orglett.6b02911"},{"key":"4357_CR39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1021\/acscentsci.6b00061","volume":"2","author":"MS Sanford","year":"2016","unstructured":"Sanford MS, Scott PJ. Moving metal-mediated 18F-fluorination from concept to clinic. ACS Cent Sci. 2016;2:128\u201330. \n                    https:\/\/doi.org\/10.1021\/acscentsci.6b00061\n                    \n                  .","journal-title":"ACS Cent Sci"},{"key":"4357_CR40","doi-asserted-by":"publisher","first-page":"9941","DOI":"10.1038\/srep09941","volume":"5","author":"K Sander","year":"2015","unstructured":"Sander K, Gendron T, Yiannaki E, Cybulska K, Kalber TL, Lythgoe MF, et al. Sulfonium salts as leaving groups for aromatic labelling of drug-like small molecules with fluorine-18. Sci Rep. 2015;5:9941. \n                    https:\/\/doi.org\/10.1038\/srep09941\n                    \n                  .","journal-title":"Sci Rep"},{"key":"4357_CR41","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1002\/anie.201404436","volume":"53","author":"M Tredwell","year":"2014","unstructured":"Tredwell M, Preshlock SM, Taylor NJ, Gruber S, Huiban M, Passchier J, et al. A general copper-mediated nucleophilic 18F fluorination of arenes. Angew Chem Int Ed Engl. 2014;53:7751\u20135. \n                    https:\/\/doi.org\/10.1002\/anie.201404436\n                    \n                  .","journal-title":"Angew Chem Int Ed Engl"},{"key":"4357_CR42","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. P Natl Acad Sci USA. 2004;101:9861\u20136. \n                    https:\/\/doi.org\/10.1073\/pnas.0308208101\n                    \n                  .","journal-title":"P Natl Acad Sci USA"},{"key":"4357_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.mibio.2003.09.009","volume":"5","author":"M Laruelle","year":"2003","unstructured":"Laruelle M, Slifstein M, Huang Y. Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography. Mol Imaging Biol. 2003;5:363\u201375.","journal-title":"Mol Imaging Biol"},{"key":"4357_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neulet.2018.07.038","volume":"691","author":"Z Cai","year":"2019","unstructured":"Cai Z, Li S, Matuskey D, Nabulsi N, Huang Y. PET imaging of synaptic density: a new tool for investigation of neuropsychiatric diseases. Neurosci Lett. 2019;691:44\u201350. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2018.07.038\n                    \n                  .","journal-title":"Neurosci Lett"},{"key":"4357_CR45","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1021\/acschemneuro.8b00526","volume":"10","author":"S Li","year":"2019","unstructured":"Li S, Cai Z, Wu X, Holden D, Pracitto R, Kapinos M, et al. Synthesis and in vivo evaluation of a novel PET radiotracer for imaging of synaptic vesicle glycoprotein 2A (SV2A) in nonhuman Primates. ACS Chem Neurosci. 2019;10:1544\u201354. \n                    https:\/\/doi.org\/10.1021\/acschemneuro.8b00526\n                    \n                  .","journal-title":"ACS Chem Neurosci"},{"key":"4357_CR46","doi-asserted-by":"publisher","unstructured":"Constantinescu CC, Tresse C, Zheng M, Gouasmat A, Carroll VM, Mistico L, et al. Development and in vivo preclinical imaging of Fluorine-18-labeled synaptic vesicle protein 2A (SV2A) PET tracers. Mol Imaging Biol. 2018. \n                    https:\/\/doi.org\/10.1007\/s11307-018-1260-5\n                    \n                  .","DOI":"10.1007\/s11307-018-1260-5"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04357-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04357-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04357-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T23:15:08Z","timestamp":1591398908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04357-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,7]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4357"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04357-w","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,7]]},"assertion":[{"value":"25 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the Yale University Institutional Animal Care and Use Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}